NOMIFENSINE MALEATE

NOMIFENSINE MALEATE Struktur
24526-64-5
CAS-Nr.
24526-64-5
Englisch Name:
NOMIFENSINE MALEATE
Synonyma:
linamiphen;Nomifensin;Nomifenison;NOMIFENSINE MALEATE USP/EP/BP;Dopamine Receptor,Inhibitor,Nomifensine,inhibit;1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquinolinamin;2-Methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine;2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine;8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline;8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline
CBNumber:
CB5503980
Summenformel:
C16H18N2
Molgewicht:
238.33
MOL-Datei:
24526-64-5.mol

NOMIFENSINE MALEATE Eigenschaften

Schmelzpunkt:
179-181°
Siedepunkt:
370.93°C (rough estimate)
Dichte
0.9597 (rough estimate)
Brechungsindex
1.5000 (estimate)
storage temp. 
2-8°C(protect from light)
Löslichkeit
DMF: 25 mg/ml; DMSO: 25 mg/ml; Ethanol: 10 mg/ml; PBS (pH 7.2): Partially soluble
Aggregatzustand
A crystalline solid
pka
7.85±0.40(Predicted)
Farbe
Light yellow to yellow
EPA chemische Informationen
Nomifensine (24526-64-5)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn
R-Sätze: 22-36/37/38
S-Sätze: 26-36
RIDADR  3249
WGK Germany  3
RTECS-Nr. NX4912800
HazardClass  6.1(b)
PackingGroup  III
Giftige Stoffe Daten 24526-64-5(Hazardous Substances Data)
Toxizität TDLo orl-wmn: 7 mg/kg/7D-I:BLD BMJOAE 288,830,84
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
Sicherheit
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

NOMIFENSINE MALEATE Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R22:Gesundheitsschädlich beim Verschlucken.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.

S-Sätze Betriebsanweisung:

S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.

Beschreibung

Nomifensine is an inhibitor of norepinephrine (NE) and dopamine (DA) reuptake. It inhibits uptake of NE, DA, and serotonin (5-HT) in rat brain synaptosomes with IC50 values of 6.6, 48, and 830 nM, respectively. It is selective for DA, NE, and 5-HT uptake inhibition over binding to dopamine D2, α1- adrenergic-, 5-HT2, and muscarinic receptors (IC50s = 43,000, 1,200, 3,800, and >13,000 nM, respectively, in rat brain membranes). Nomifensine is selective for inhibition of NE over DA uptake in vivo with minimal inhibitory doses of 28 and less than 57 μmol/kg, respectively. It decreases the time Wistar Kyoto, but not Sprague-Dawley, rats spend immobile in the forced swim test but also increases locomotor activity in the open field test in Wistar Kyoto and Sprague-Dawley rats when administered at a chronic dose of 10 mg/kg.

Verwenden

A novel antidepressant distinguished from existing tricyclic and tetracyclic antidepressants by its bicyclic structure.

Definition

ChEBI: An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Weltgesundheitsorganisation (WHO)

Nomifensine, an antidepressant indicated for the treatment of a wide range of depressive illness, was introduced in 1976. Subsequently rare cases of haemolytic anaemia - sometimes fatal - thrombocytopenia, hepatotoxicity and fever were associated with the use of the drug. Following discussions with regulatory authorities in the United Kingdom and the Federal Republic of Germany the major manufacturer withdrew all preparations containing nomifensine worldwide in January 1986.

Sicherheitsprofil

Poison by ingestion andintravenous routes. Human systemic effects by ingestion:diffuse hepatitis, hemorrhage and decrease in the numberof blood platelets (thrombocytopenia). When heated todecomposition it emits toxic fumes of NOx.

NOMIFENSINE MALEATE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


NOMIFENSINE MALEATE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 57)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Daken Advanced Materials Co.,Ltd
+86-371-66670886
info@dakenam.com China 16854 58
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29898 58
Chongqing Chemdad Co., Ltd
+86-023-6139-8061 +86-86-13650506873
sales@chemdad.com China 39916 58
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63711 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 24822 58
Aromsyn Co., Ltd.
+86-0571-85585865 +8613336024896
CB@aromsyn.com China 19185 58
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
Xuzhou B&C Chemical Co.,Ltd
+86-15190678838 +86-15190678838
info@bcpharma.com China 1302 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8474 58
Shanghai Acmec Biochemical Technology Co., Ltd.
+undefined18621343501
product@acmec-e.com China 33350 58

24526-64-5()Verwandte Suche:


  • 1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquinolinamin
  • 1,2,3,4-tetrahydro-8-amino-2-methyl-4-phenyl-isoquinolin
  • 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine
  • 8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline
  • 8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline
  • 8-Isoquinolinamine, 1,2,3,4-tetrahydro-2-methyl-4-phenyl-
  • linamiphen
  • Nomifenison
  • Nomifensin
  • 2-Methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine
  • NOMIFENSINE MALEATE USP/EP/BP
  • Dopamine Receptor,Inhibitor,Nomifensine,inhibit
  • 24526-64-5
  • Amines
  • Aromatics
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Copyright 2019 © ChemicalBook. All rights reserved